Literature DB >> 35928341

Nitric Oxide on Extracorporeal Life Support-Circuit Modifications for a Safe Therapy.

Carlisle O'Meara1, Joseph Timpa1, Giles Peek2, Melissa Sindelar1, Jenny Ross3, Justin Raper4, Jonathan W Byrnes5.   

Abstract

Nitric oxide (NO) incorporation into the sweep gas of the extracorporeal life support (ECLS) circuit has been proposed as a strategy to ameliorate the insults caused by the systemic inflammatory response. This technical study describes circuit modifications allowing nitric oxide to be incorporated into the circuit and describing and validating the oxygenator sweep flow rates necessary to achieve consistent safe delivery of the therapy. For patients requiring sweep rates less than 2 L/min, a simplified setup, incorporating a pressure relief valve/low flow meter in the gas delivery line, was placed in line between the blender/NO injector module and the NO sampling port/oxygenator. This setup allows titration of sweep to low flows without the need to blend in CO2 while maintaining the manufacturer recommendation of a minimum 2 L/min of sweep gas to safely deliver NO without nitric dioxide (NO2) buildup. This setup was tested three times at three different FiO2 rates and eleven different desired low sweep flows to test for reproducibility and safety to build an easy-to-follow chart for making gas flow changes. For patients requiring oxygenator sweep rates greater than 2 L/min, the pressure relief valve/low flow meter apparatus is not needed. Maintaining consistent sweep rate and nitric oxide delivery is required in order to utilize this therapy in ECLS. We demonstrated gas delivery across all flow rates. There were no issues delivering 20 parts per million of NO and negligible NO2 detection. The results from testing this setup were used to provide the specialist a chart at which to set the low flow meter to produce the desired flow rate at which the patient needs. This has been used clinically on 15 ECLS patients with success. © Copyright 2022 AMSECT.

Entities:  

Keywords:  circuit modification; extracorporeal life support; extracorporeal membrane oxygenation; inflammation; nitric oxide; platelet activation; pressure relief valve.; thrombosis

Mesh:

Substances:

Year:  2022        PMID: 35928341      PMCID: PMC9302404          DOI: 10.1182/ject-142-147

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  14 in total

Review 1.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

Authors:  D Paparella; T M Yau; E Young
Journal:  Eur J Cardiothorac Surg       Date:  2002-02       Impact factor: 4.191

2.  Effect of nitric oxide upon gas transfer and structural integrity of a polypropylene membrane oxygenator.

Authors:  S C Body; D FitzGerald; C Voorhees; E Hansen; C Crowley; M E Voorhees; S K Shernan
Journal:  ASAIO J       Date:  1999 Nov-Dec       Impact factor: 2.872

3.  Safety of nitric oxide added to the ECMO circuit: a pilot study in children.

Authors:  Roberto Chiletti; Steve Horton; Andrzej Bednarz; Robert Bartlett; Warwick Butt
Journal:  Perfusion       Date:  2017-07-21       Impact factor: 1.972

4.  The Safe Addition of Nitric Oxide into the Sweep Gas of the Extracorporeal Circuit during Cardiopulmonary Bypass and Extracorporeal Life Support.

Authors:  Martin Bennett; Clarke Thuys; Simon Augustin; Brad Schultz; Steve Bottrell; Alison Horton; Andrzej Bednarz; Steve Horton
Journal:  J Extra Corpor Technol       Date:  2018-12

5.  The effects of nitric oxide on coagulation during simulated extracorporeal membrane oxygenation.

Authors:  E D Rauch; A H Stammers; B L Mejak; S N Vang; T W Viessman
Journal:  J Extra Corpor Technol       Date:  2000-12

6.  Cardiopulmonary bypass tubes and prime solutions stimulate neutrophil adhesion molecules.

Authors:  M H el Habbal; L J Smith; M J Elliott; S Strobel
Journal:  Cardiovasc Res       Date:  1997-01       Impact factor: 10.787

7.  Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children--a randomized trial.

Authors:  Paul A Checchia; Ronald A Bronicki; Jared T Muenzer; David Dixon; Steve Raithel; Sanjiv K Gandhi; Charles B Huddleston
Journal:  J Thorac Cardiovasc Surg       Date:  2012-12-08       Impact factor: 5.209

8.  Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial.

Authors:  Christopher James; Johnny Millar; Stephen Horton; Christian Brizard; Charlotte Molesworth; Warwick Butt
Journal:  Intensive Care Med       Date:  2016-09-30       Impact factor: 17.440

9.  Inflammatory Effects of Blood-Air Interface in a Porcine Cardiopulmonary Bypass Model.

Authors:  Benjamin D Carr; Thomas J Johnson; Amalia Gomez-Rexrode; Azmath Mohammed; Megan Coughlin; John M Toomasian; Alvaro Rojas-Pena; Robert H Bartlett; Jonathan W Haft
Journal:  ASAIO J       Date:  2020-01       Impact factor: 3.826

10.  Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial.

Authors:  Luregn J Schlapbach; Stephen Brian Horton; Debbie Amanda Long; John Beca; Simon Erickson; Marino Festa; Yves d'Udekem; Nelson Alphonso; David Winlaw; Kerry Johnson; Carmel Delzoppo; Kim van Loon; B Gannon; Jonas Fooken; Antje Blumenthal; Paul Young; Mark Jones; Warwick Butt; Andreas Schibler
Journal:  BMJ Open       Date:  2019-08-15       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.